General Releases Releases
Ligand Pharmaceuticals Announces Second Quarter Results
Aug 5, 2010
|
Ligand to Present at the BMO Capital Markets Healthcare Conference on August 5
Jul 26, 2010
|
Ligand to Report Second Quarter Results on August 5th
Jul 22, 2010
|
Ligand Launches New Corporate Web Site
Jul 15, 2010
|
Ligand to Webcast Analyst Day on June 24
Jun 21, 2010
|
Ligand Board Authorizes Reverse Stock Split and $10 Million Share Repurchase
Jun 15, 2010
|
Ligand to Present at the Jefferies Global Life Sciences Conference on June 9
Jun 2, 2010
|
Ligand Acquired Milestone and Royalty Interest in AstraZeneca IL-9 Program for Asthma
May 21, 2010
|
Ligand to Present at the MDB Capital Group Bright Lights Conference on May 11
May 6, 2010
|
Ligand Pharmaceuticals Announces First Quarter Results
May 5, 2010
|
Ligand to Report First Quarter Results on May 5th
Apr 26, 2010
|
Ligand Earns $6.5 Million Milestone Payment from Roche
Apr 20, 2010
|
Ligand Presents First-in-Human Phase I Data on Lead SARM Molecule LGD-4033 at the International Congress of Endocrinology
Mar 29, 2010
|
Ligand Announces Approval for Revolade(R) in Europe
Mar 12, 2010
|
Ligand to Present at the Cowen & Company 30th Annual Healthcare Conference on March 11
Mar 1, 2010
|
Ligand Announces Fourth Quarter and Full Year 2009 Consolidated Financial Results
Feb 9, 2010
|
Ligand to Report Fourth Quarter Results on February 9th
Feb 1, 2010
|
Ligand Completes Acquisition of Metabasis
Jan 28, 2010
|
Ligand Earns $1 Million in Milestone Payment from Merck & Co., Inc.
Jan 7, 2010
|
Ligand Completes Neurogen Acquisition
Dec 23, 2009
|
|
|
